261 related articles for article (PubMed ID: 18189292)
1. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.
Kapp DS; Shin JY; Chan JK
Cancer; 2008 Feb; 112(4):820-30. PubMed ID: 18189292
[TBL] [Abstract][Full Text] [Related]
2. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
3. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
[TBL] [Abstract][Full Text] [Related]
4. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
Garg G; Kruger M; Christensen C; Deppe G; Toy EP
Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
[TBL] [Abstract][Full Text] [Related]
7. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
[TBL] [Abstract][Full Text] [Related]
8. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
[TBL] [Abstract][Full Text] [Related]
9. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
10. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
[TBL] [Abstract][Full Text] [Related]
11. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
12. The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone.
Mahdi H; Nutter B; Abdul-Karim F; Amarnath S; Rose PG
J Gynecol Oncol; 2016 Mar; 27(2):e19. PubMed ID: 26463437
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
[TBL] [Abstract][Full Text] [Related]
14. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
[TBL] [Abstract][Full Text] [Related]
16. Impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer: analysis for white, African, and East Asian Americans.
Hashiguchi Y; Hase K; Ueno H; Shinto E; Naito Y; Kajiwara Y; Kuroda T; Yamamoto J; Mochizuki H
Ann Surg Oncol; 2012 May; 19(5):1517-28. PubMed ID: 22012028
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic differences in upper-tract urothelial cancer.
Hosain GM; Khan MM; Amiel GE; Lerner SP; Latini DM; Chen GJ
Ethn Dis; 2012; 22(3):295-301. PubMed ID: 22870572
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive lymphadenectomy and survival prediction in uterine serous cancer patients after surgery: A population-based analysis.
Li H; Xie X; Liu Y; Huang X; Lin H; Li J; Lin Z
Eur J Surg Oncol; 2020 Jul; 46(7):1339-1346. PubMed ID: 32402510
[TBL] [Abstract][Full Text] [Related]
19. Race influences stage-specific survival in gastric cancer.
Howard JH; Hiles JM; Leung AM; Stern SL; Bilchik AJ
Am Surg; 2015 Mar; 81(3):259-67. PubMed ID: 25760201
[TBL] [Abstract][Full Text] [Related]
20. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]